On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are M.d. Biosciences (Israel) Ltd's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€174k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- OSTEOIMMUNEPartner
OSTEOIMMUNE - Unraveling the Interactions between the Immune System and Bone
FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗
€174ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Karolinska InstitutetSweden · 1 shared project
- Stichting Radboud UniversiteitNetherlands · 1 shared project
- University of GlasgowUnited Kingdom · 1 shared project
- Universitat ZurichSwitzerland · 1 shared project
- Universitatsklinikum ErlangenGermany · 1 shared project
- Erevnitiko Kentro Vioiatrikon Epistimon Alexandros FlemingkGreece · 1 shared project
- Universitatsklinikum JenaGermany · 1 shared project
- Deutsches Rheuma ForschungszentrumberlinGermany · 1 shared project
- Novimmune SASwitzerland · 1 shared project
- Draconispharma SLSpain · 1 shared project
- Md Biosciences Inflammations Discovery Service LimitedUnited Kingdom · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- drug discovery
- genetics
- history
- immunology
- rheumatology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗